“…For instance, control of viral infections can be compromised in GzmA -/mice (Loh et al, 2004;Mullbacher et al, 1996;Pereira et al, 2000;Riera et al, 2000), with cytotoxic lymphocytes from these mice reported to be less able to kill target cells (Pardo et al, 2002;Pardo et al, 2004;Shresta et al, 1999;Susanto et al, 2013). Like granzyme B (GzmB), GzmA has thus been classified as a cytotoxic granzyme (Golstein and Griffiths, 2018;Mpande et al, 2018;Muraro et al, 2017;Zhou et al, 2020), although in several studies a role for GzmA in mediating cellular cytotoxicity was not observed (Ebnet et al, 1995;Joeckel and Bird, 2014;Regner et al, 2009;Regner et al, 2011;Smyth et al, 2003). In a range of settings GzmA has also been associated with the promotion of inflammation, providing an additional or alternative view of its physiological role, although consensus on mechanisms has remained elusive (Metkar et al, 2008;Park et al, 2020;Santiago et al, 2020;Santiago et al, 2017;Schanoski et al, 2019;Shimizu et al, 2019; van Daalen et al, 2020;Wensink et al, 2015;Wilson et al, 2017), with a number of potential intracellular and extracellular targets for GzmA reported.…”